Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients were granted access to low-THC marijuana oil. The Georgia State Board of Pharmacy recently made the decision to endorse more cannabis oil sale outlets.

Oil 98

Oil Patients Access THC 98

NORML

MAY 26, 2020

Thus, it enables individualization of medical cannabis regimens that can be evaluated pharmacokinetically and pharmacodynamically by accepted pharmaceutical models.” Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

Clinical Trials 250

Clinical Trials Chronic Pain Cannabinoids Patients 250

CannaTech

JANUARY 16, 2019

Pharmaceutical grade cannabis is relatively new in parts of the world. Patients, and their treatment, therefore, are the priority. Treatment options may be limited by government-approved imports, a practitioner’s prescription or pharmacy stock. Legal access does not necessarily equate to financial access.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Law Report

AUGUST 17, 2021

.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. Chief Medical Officer of Marinus. “We Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “This year, my focus was on program improvements to further expand both access and therapeutic value to benefit the health and well-being of all Virginians.”

Law 260

Law Patients Access Oil 260

MMJ Recs

FEBRUARY 3, 2024

Pennsylvania Medical Cannabis Program and Philadelphia Marijuana Dispensaries The Pennsylvania Medical Cannabis Program serves as the foundation for medical marijuana accessibility in Philadelphia. In Philadelphia, patients must be diagnosed with specific medical conditions to be eligible for medical cannabis treatment.

Legislation 52

Legislation Law Marijuana Dispensary 52

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. The post RYAH Group Ships Devices for Use in Pilot Program with Medicann in Jersey, Channel Islands appeared first on CannabisFN. to reach 3.2

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

DECEMBER 5, 2021

Funders are endorsing MAPS’ mission and pursuit of mass mental health backed by 35 years of innovative leadership, governance, programs, and strategies. Getting MAPS out ahead of the industry will create a commercial and cultural bar that puts patient access first.”.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

MMJ Recs

APRIL 1, 2024

We’re exploring the world of CBD, uncovering the benefits of CBD in medical marijuana, its impact on health, its potential as a treatment option, and what you need to know about its use in medical marijuana. CBD: A Promising Treatment Option One of the most compelling aspects of CBD is its versatility as a treatment option.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. “Our Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

The Cannigma

JUNE 25, 2022

Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Poland’s medical cannabis program. Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? VA resident? West Virginia.

Legislation 239

Legislation Patients Decriminalization Access 239

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

The Cannigma

JUNE 19, 2022

The country has had a medical cannabis program since 2015. Colombia’s medical cannabis program allows for research and product development, as well as prescriptions. Today, patients can access cannabis products with a prescription from a doctor. Cannabis in Colombia.

Legalization 97

Legalization Decriminalization Research and Development Consumption 97

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Eric Rahn, Managing Director. Complicating matters, each state has their own set of laws, which are rapidly evolving.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. That is perhaps the biggest lie that is being perpetuated on the Alabama public today.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Cannabis Law Report

JANUARY 23, 2022

Lophos Pharma is a psychedelic research company primarily focused on novel therapeutic treatments derived from Peyote (Lophophora williamsii). Claire gained substantial pharmaceutical experience from her work in the biotechnology industry before transferring to cannabis in 2017. Greenridez 2.0 Acquisitions Corp.

History 52

History Pharmaceutical Compliance Compliance 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Position Requirements.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Thirty-three states and the District of Columbia have enacted medical marijuana programs. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Current Issues in Marijuana Regulation. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

MMJ Recs

MAY 15, 2022

But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. MMJ in Virginia is becoming more available, and the program is now able to help more people. Recently, Virginia legalization has changed in several ways.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Canna Law Blog

NOVEMBER 10, 2020

We discussed how licensed facilities won’t be up and running for a few more years, and how, in the meantime, people will have to make do with general decriminalization under Measure 109 and maybe, in certain cases, reliance on Right to Try access. It’s quite restrictive. Or, it could be because FDA is sort of a drag about everything.

Therapy 79

Therapy Clinical Trials Decriminalization Patients 79

Cannabis Law Report

SEPTEMBER 1, 2021

Doug Drysdale is an experienced director, having been CEO and chairman of the board of Nasdaq-listed companies and pharmaceutical firms. A pharmaceutical executive and pharmacologist, Barrow has led drug development teams and navigated the pharmaceutical approval landscape. After Approval, It’s Off to Treatment Clinics.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

The Cannigma

AUGUST 26, 2021

Australia has a legal medical marijuana program, and while recreational cannabis remains illegal on the federal level, the enforcement of cannabis laws and the penalties handed out can differ widely from one territory to another. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Canna Law Blog

NOVEMBER 27, 2021

Medicines and Healthcare Products Regulatory Agency for one of its DMT products for the treatment of major depressive disorder. Several months ago, Canada-based Algernon Pharmaceuticals submitted a request to U.S. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction.

Therapy 88

Therapy Clinical Trials DEA Microdosing 88

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Cannabis Law Report

JULY 24, 2021

At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer. The company is scaling its proprietary research and development methods in order to become one of the first to produce and bring to market psilocybin-based treatments.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

PrestoDoctor

SEPTEMBER 6, 2023

One of the primary reasons for this shift is the growing acceptance and accessibility of cannabis as an alternative pain management option. Many individuals prefer the idea of using a plant-based substance rather than relying on synthetic pharmaceuticals. This makes it an attractive alternative to prescription medications.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

MMJ Recs

JANUARY 17, 2024

Traditional treatments may not always provide the desired relief, leading many individuals to explore alternative options like medical marijuana. Cannabis can also enhance the efficacy of conventional treatments, potentially allowing patients to reduce reliance on traditional pharmaceuticals with a myriad of side effects.

Strains 98

Strains Marijuana Indica Microdosing 98

Cannabis Law Report

MARCH 19, 2022

Publishing online and in print with open access options, Psychedelic Medicine will provide an authoritative, high-profile forum for groundbreaking original research papers, review articles, captivating front matter, debate, and commentary. Mary Ann Liebert Inc., This important new journal ensures its integrity of content and impact.”.

Medicine 52

Medicine Decriminalization Pharmaceutical Topical 52

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Before delving further into this question, let’s consider the context in which the government implemented its medical program. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

SpeedWeed

AUGUST 27, 2021

What role does the “informal” researcher play in advancing knowledge about the drug—particularly if the investigation is not tied to any kind of formal program? Furthermore, patient access, just about everywhere, is one of the biggest issues in every country where cannabis is becoming legal, even for medical reasons.

Cultivation 67

Cultivation Research and Development Hybrid Pharmaceutical 67

Cannabis Law Report

JANUARY 18, 2022

Texas Original Compassionate Cultivation assembled a focus group of veterans suffering from PTSD to evaluate symptom response, product preference and effects on supplemental pharmaceutical consumption. The focus group consisted of veterans suffering from PTSD who qualify for medical cannabis under the expanded Compassionate Use Program.

Patients 52

Patients Tincture Pharmaceutical Cultivation 52

SpeedWeed

AUGUST 9, 2021

Argentinian health authorities are now providing access to cannabis derivatives for medicinal, therapeutic and palliative purposes. The hospital’s young patients will now receive treatment from pharmaceutical-grade cannabis oil, purified and highly concentrated. The delivery was a long-awaited result of Law 27,350.

Epilepsy 52

Epilepsy Research and Development Medicine Patients 52

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Conducting Psilocybin Integration (14 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program. Prior to UroGen, Mr. Barbera held various leadership roles at Dendreon Pharmaceuticals, Allergan, and Medimmune, among others.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66